Pulmonary, Critical Care and Sleep Medicine
The Section of Pulmonary, Critical Care, and Sleep Medicine at Baylor College of Medicine is nationally recognized for its excellence in healthcare, research and education.
The section has total research support of $4.8 million from federal and private research grants including lung cancer, asthma, COPD, pulmonary hypertension, pulmonary fibrosis, transitional medicine, lung transplant, and cystic fibrosis.
Many physicians from the section are national and international experts. Together, they offer an incredibly large array of services, from general pulmonary and sleep medicine to highly specialized advanced lung diseases, such as including pulmonary hypertension, pulmonary fibrosis, adult cystic fibrosis, COPD/asthma, interstitial lung disease, lung and heart-lung transplantation, critical care, and interventional pulmonology.
The section offers four fellowship programs, including Pulmonary & Critical Care, Critical Care Medicine, Lung Transplantation, and Sleep Medicine. Many alumni and former fellows can be found in academic, research and healthcare leadership roles.
- Electronic algorithms to identify delays in patient follow-upMay 20, 2015
- Researchers have created electronic triggers to identify delays in telling patients about an abnormal lung image.
- Risks of side effects when treating deadly heart-related illness studiedMay 15, 2015
- Continued review of outcomes of people who suffer from non-valvular atrial fibrillation treated with rivaroxaban have shown that the likelihood of a major bleeding event, a known side effect of this treatment, increases with age.
- Baylor faculty recognized for excellence in clinical careMay 15, 2015
- A group of Baylor College of Medicine faculty members received the College’s Master Clinician and Rising Star Clinician Awards for excellence in patient care at a May 14 ceremony.
- Baylor Miraca Genetics Laboratories launches enhanced clinical exome sequencing test, faster delivery of resultsMay 14, 2015
- Baylor Miraca Genetics Laboratories announced today the launch of an enhanced clinical exome sequencing test, a new option for physicians that speeds up delivery of final results to two-three weeks from three months.
- Safety switch preserves beneficial effects of cell therapyMay 14, 2015
- Researchers have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.